{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:38:22Z","timestamp":1794573502636,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62227803"],"award-info":[{"award-number":["62227803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Social Development Project","award":["BE2022812"],"award-info":[{"award-number":["BE2022812"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02758-w","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T10:36:36Z","timestamp":1746786996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Xin","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yewei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"issue":"9","key":"2758_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"2758_CR2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"4","key":"2758_CR3","first-page":"691","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702.","journal-title":"Gut"},{"issue":"3","key":"2758_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/ijms17030367","volume":"17","author":"P Wainwright","year":"2016","unstructured":"Wainwright P, Byrne CD. Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome. Int J Mol Sci. 2016;17(3):367.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2758_CR5","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.jhepr.2024.101092","volume":"6","author":"F Bril","year":"2024","unstructured":"Bril F, Kalavalapalli S, Lomonaco R, et al. Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants. JHEP Rep Innov Hepatol. 2024;6(7):101092.","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"21","key":"2758_CR6","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.jacc.2007.01.088","volume":"49","author":"J Jeppesen","year":"2007","unstructured":"Jeppesen J, Hansen TW, Rasmussen S, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007;49(21):2112\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2758_CR7","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-223.","journal-title":"Am J Physiol"},{"key":"2758_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/hmbci-2023-0061","volume":"45","author":"K Rani","year":"2024","unstructured":"Rani K, Patil P, Bharti P, Kumar S, Prabhala S. The undervalued league of insulin resistance testing: uncovering their importance. Hormone Mol Biol Clin Invest. 2024;45:99\u2013104.","journal-title":"Hormone Mol Biol Clin Invest"},{"key":"2758_CR9","doi-asserted-by":"publisher","first-page":"4678526","DOI":"10.1155\/2020\/4678526","volume":"2020","author":"A S\u00e1nchez-Garc\u00eda","year":"2020","unstructured":"S\u00e1nchez-Garc\u00eda A, Rodr\u00edguez-Guti\u00e9rrez R, Mancillas-Adame L, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020:4678526.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"2758_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12933-024-02173-7","volume":"23","author":"XZ Hou","year":"2024","unstructured":"Hou XZ, Lv YF, Li YS, et al. Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study. Cardiovasc Diabetol. 2024;23(1):86.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2758_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-024-02269-0","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2758_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.aohep.2020.03.001","volume":"19","author":"A Lonardo","year":"2020","unstructured":"Lonardo A, Mantovani A, Lugari S, Targher G. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. Ann Hepatol. 2020;19(4):359\u201366.","journal-title":"Ann Hepatol"},{"issue":"3","key":"2758_CR13","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3):e0149731.","journal-title":"PLoS ONE"},{"issue":"3","key":"2758_CR14","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","volume":"14","author":"J Lim","year":"2019","unstructured":"Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007\u20132010 Korean National Health and Nutrition Examination Survey. PLoS ONE. 2019;14(3):e0212963.","journal-title":"PLoS ONE"},{"issue":"1","key":"2758_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2015;41(1):65\u201376.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2758_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1172\/JCI27300","volume":"116","author":"DB Savage","year":"2006","unstructured":"Savage DB, Choi CS, Samuel VT, et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Investig. 2006;116(3):817\u201324.","journal-title":"J Clin Investig"},{"issue":"1","key":"2758_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cmet.2005.06.006","volume":"2","author":"S Neschen","year":"2005","unstructured":"Neschen S, Morino K, Hammond LE, et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA: glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2005;2(1):55\u201365.","journal-title":"Cell Metab"},{"issue":"31","key":"2758_CR18","doi-asserted-by":"publisher","first-page":"32345","DOI":"10.1074\/jbc.M313478200","volume":"279","author":"VT Samuel","year":"2004","unstructured":"Samuel VT, Liu ZX, Qu X, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem. 2004;279(31):32345\u201353.","journal-title":"J Biol Chem"},{"issue":"3","key":"2758_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"JE Lambert","year":"2014","unstructured":"Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology. 2014;146(3):726\u201335.","journal-title":"Gastroenterology"},{"issue":"8","key":"2758_CR20","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2337\/diab.37.8.1020","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes. 1988;37(8):1020\u20134.","journal-title":"Diabetes"},{"issue":"5","key":"2758_CR21","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/gast.2001.23256","volume":"120","author":"AJ Sanyal","year":"2001","unstructured":"Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120(5):1183\u201392.","journal-title":"Gastroenterology"},{"issue":"6","key":"2758_CR22","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny NE, Parks EJ, Browning JD, Burgess SC. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 2011;14(6):804\u201310.","journal-title":"Cell Metab"},{"issue":"10290","key":"2758_CR23","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet (London, England). 2021;397(10290):2212\u201324.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"2758_CR24","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.diabet.2020.101215","volume":"47","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD. NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment. Diabetes Metab. 2021;47(2):101215.","journal-title":"Diabetes Metab"},{"issue":"11","key":"2758_CR25","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.2337\/diacare.25.11.2022","volume":"25","author":"V Jayagopal","year":"2002","unstructured":"Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL. Biological variation of homeostasis model assessment-derived insulin resistance in type 2 diabetes. Diabetes Care. 2002;25(11):2022\u20135.","journal-title":"Diabetes Care"},{"issue":"1","key":"2758_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2758_CR27","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary DL, Pratisthita LB, Fitri NA, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride\/glucose index. Diabetes Metab Syndrome. 2022;16(8):102581.","journal-title":"Diabetes Metab Syndrome"},{"key":"2758_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12933-014-0159-y","volume":"13","author":"A Tenenbaum","year":"2014","unstructured":"Tenenbaum A, Klempfner R, Fisman EZ. Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovasc Diabetol. 2014;13:159.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2758_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1210\/jc.2015-3111","volume":"101","author":"F Bril","year":"2016","unstructured":"Bril F, Sninsky JJ, Baca AM, et al. Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD. J Clin Endocrinol Metab. 2016;101(2):644\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2758_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-018-0042-6","volume":"40","author":"M Knapp","year":"2019","unstructured":"Knapp M, Tu X, Wu R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. 2019;40(1):1\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2758_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-024-02152-y","volume":"23","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang Y, Chen S, et al. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study. Cardiovasc Diabetol. 2024;23(1):80.","journal-title":"Cardiovasc Diabetol"},{"issue":"46","key":"2758_CR32","doi-asserted-by":"publisher","first-page":"e40534","DOI":"10.1097\/MD.0000000000040534","volume":"103","author":"W Ding","year":"2024","unstructured":"Ding W, Fang C, Wang L, Fang C. Triglyceride-glucose index and risk of all-cause and cardiovascular mortality in patients with cardiovascular disease: analysis from 1999 to 2018 NHANES data. Medicine. 2024;103(46):e40534.","journal-title":"Medicine"},{"issue":"1","key":"2758_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12967-016-1020-8","volume":"14","author":"S Zheng","year":"2016","unstructured":"Zheng S, Shi S, Ren X, et al. Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study. J Transl Med. 2016;14(1):260.","journal-title":"J Transl Med"},{"issue":"11","key":"2758_CR34","doi-asserted-by":"publisher","first-page":"E1756","DOI":"10.1210\/jc.2011-0615","volume":"96","author":"T McLaughlin","year":"2011","unstructured":"McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab. 2011;96(11):E1756-1760.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2758_CR35","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbrc.2012.08.024","volume":"425","author":"Y Arita","year":"2012","unstructured":"Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. Biochem Biophys Res Commun. 2012;425(3):560\u20134.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2758_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/obr.12551","volume":"18","author":"GA Bray","year":"2017","unstructured":"Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715\u201323.","journal-title":"Obes Rev"},{"issue":"4","key":"2758_CR37","doi-asserted-by":"publisher","first-page":"100726","DOI":"10.1016\/j.aohep.2022.100726","volume":"28","author":"D Zhao","year":"2023","unstructured":"Zhao D, Cui H, Shao Z, Cao L. Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease. Ann Hepatol. 2023;28(4):100726.","journal-title":"Ann Hepatol"},{"issue":"1","key":"2758_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12877-024-04992-5","volume":"24","author":"L Ding","year":"2024","unstructured":"Ding L, Fu B, Zhang H, et al. The impact of triglyceride glucose-body mass index on all-cause and cardiovascular mortality in elderly patients with diabetes mellitus: evidence from NHANES 2007\u20132016. BMC Geriatr. 2024;24(1):356.","journal-title":"BMC Geriatr"},{"issue":"6","key":"2758_CR39","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/jch.13878","volume":"22","author":"ZY Zeng","year":"2020","unstructured":"Zeng ZY, Liu SX, Xu H, et al. Association of triglyceride glucose index and its combination of obesity indices with prehypertension in lean individuals: a cross-sectional study of Chinese adults. J Clin Hypertens (Greenwich). 2020;22(6):1025\u201332.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"23","key":"2758_CR40","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/nu14234969","volume":"14","author":"J Wang","year":"2022","unstructured":"Wang J, Yan S, Cui Y, et al. The diagnostic and prognostic value of the triglyceride-glucose index in metabolic dysfunction-associated fatty liver disease (MAFLD): a systematic review and meta-analysis. Nutrients. 2022;14(23):4969.","journal-title":"Nutrients"},{"issue":"1","key":"2758_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12933-023-02047-4","volume":"22","author":"J Dou","year":"2023","unstructured":"Dou J, Guo C, Wang Y, et al. Association between triglyceride glucose-body mass and one-year all-cause mortality of patients with heart failure: a retrospective study utilizing the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):309.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2758_CR42","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","volume":"35","author":"K Sawada","year":"2023","unstructured":"Sawada K, Chung H, Softic S, Moreno-Fernandez ME, Divanovic S. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metab. 2023;35(11):1852\u201371.","journal-title":"Cell Metab"},{"issue":"5","key":"2758_CR43","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","volume":"15","author":"CK Glass","year":"2012","unstructured":"Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15(5):635\u201345.","journal-title":"Cell Metab"},{"issue":"1","key":"2758_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12933-024-02248-5","volume":"23","author":"D Liang","year":"2024","unstructured":"Liang D, Liu C, Wang Y. The association between triglyceride-glucose index and the likelihood of cardiovascular disease in the U.S. population of older adults aged \u2265 60 years: a population-based study. Cardiovasc Diabetol. 2024;23(1):151.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2758_CR45","doi-asserted-by":"publisher","first-page":"e037948","DOI":"10.1161\/JAHA.124.037948","volume":"14","author":"SW Park","year":"2025","unstructured":"Park SW, Ning H, Carnethon MR, VanWagner LB. Cardiovascular health trajectories and prevalent metabolic dysfunction-associated steatotic liver disease in midlife: The CARDIA Study. J Am Heart Assoc. 2025;14(8):e037948.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2758_CR46","doi-asserted-by":"publisher","first-page":"11278","DOI":"10.1038\/s41598-025-94651-5","volume":"15","author":"Y Ou","year":"2025","unstructured":"Ou Y, Qin Z, Wang P, Zou F. Serum uric acid to high-density lipoprotein cholesterol ratio predicts all-cause mortality in adults with metabolic dysfunction associated steatotic liver disease. Sci Rep. 2025;15(1):11278.","journal-title":"Sci Rep"},{"issue":"4","key":"2758_CR47","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology (Baltimore, MD). 2019;70(4):1457\u201369.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"11","key":"2758_CR48","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1111\/liv.16091","volume":"44","author":"P Nasr","year":"2024","unstructured":"Nasr P, Shang Y, Wester A, et al. Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease. Liver Int. 2024;44(11):3050\u20139.","journal-title":"Liver Int"},{"issue":"5","key":"2758_CR49","first-page":"24","volume":"18","author":"AH Noriea","year":"2018","unstructured":"Noriea AH, Patel FN, Werner DA, Peek ME. A narrative review of physician perspectives regarding the social and environmental determinants of obesity. Curr DiabRep. 2018;18(5):24.","journal-title":"Curr DiabRep"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02758-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02758-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02758-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:02:56Z","timestamp":1746792176000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02758-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2758"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02758-w","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NHANES database was conducted with approval by the National Center for Health Statistics Ethics Review Board, and obtained informed written consent from all the individuals involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}